Rare diseases
Investigational molecules
Locations
Back to Germany987 clinical trials in Heilbronn, Germany across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study on Guselkumab and Etanercept for Treating Chronic Plaque Psoriasis in Children Aged 6 to 17 Years
GermanyStudy on the Effectiveness and Safety of Oral Minoxidil for Women with Androgenetic Alopecia
GermanyStudy of Giredestrant Combined with Pertuzumab-Trastuzumab (Phesgo) for Patients with Previously Untreated HER2-Positive, Estrogen Receptor-Positive Locally Advanced or Metastatic Breast Cancer
GermanyStudy on Pamapimod and Pioglitazone for COVID-19 Recovery in Non-Hospitalized Patients
GermanyStudy on the Use of Florbetaben (18F) PET Imaging for Diagnosing Cardiac AL Amyloidosis in Patients
GermanyStudy on Ribociclib and Drug Combination for Patients with Advanced HER2-Negative, Hormone Receptor Positive Breast Cancer
GermanyStudy on Botensilimab and Balstilimab for Patients with Advanced Melanoma Resistant to Previous Treatments
GermanyStudy to Compare Mezigdomide, Carfilzomib, and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma
GermanyStudy on the Safety and Effectiveness of MK-5475 for Adults with Pulmonary Hypertension and COPD
GermanyStudy on the Safety and Effectiveness of Stereotactic Body Radiotherapy with or without Pembrolizumab for Patients with Unresected Stage I or II Non-Small Cell Lung Cancer
GermanyStudy of Pembrolizumab for Patients with Advanced Solid Tumors
GermanyStudy of DKN-01 with Drug Combination for Patients with Advanced Colorectal Cancer
GermanyThe busiest research cities in the country
What the registry says about research in the country
Innovative trials focusing on Acute Myeloid Leukemia (AML) and Chronic Lymphocytic Leukemia, testing novel drug combinations to improve patient outcomes. Research includes evaluating treatments for both adult and pediatric patients with various forms of leukemia.
Studies aim to enhance survival rates and develop more effective treatment strategies for blood cancer patients.
Comprehensive studies addressing different types of breast cancer, particularly focusing on triple-negative breast cancer and HER2-positive disease. Research includes both early-stage and metastatic disease treatments.
Trials evaluate novel drug combinations and targeted therapies to improve patient outcomes.
Research focusing on various digestive system cancers, including gastric cancer, colorectal cancer, and pancreatic cancer. Studies evaluate both early-stage and advanced disease treatments.
Investigations aim to improve surgical outcomes and treatment effectiveness for GI cancers.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
